Disorders due to use of non-psychoactive substances

Description

Disorders due to use of non-psychoactive substances are characterised by the pattern and consequences of non-medical use of non-psychoactive substances. Non-psychoactive substances include laxatives, anabolic steroids, growth hormone, erythropoietin, and non-steroidal anti-inflammatory drugs. They may also include proprietary or over-the-counter medicines and folk remedies. Non-medical use of these substances may be associated with harm to the individual due to the direct or secondary toxic effects of the non-psychoactive substance on body organs and systems, or a harmful route of administration (e.g., infections due to intravenous self-administration). They are not associated with intoxication or with a dependence or withdrawal syndrome and are not recognized causes of substance-induced mental disorders.

Exclusions from above levels

QE62 – Uncomplicated bereavement
QE84 – Acute stress reaction

Child codes

6C4H.0 – Episode of harmful use of non-psychoactive substances
6C4H.1 – Harmful pattern of use of non-psychoactive substances
6C4H.Y – Other specified disorders due to use of non-psychoactive substances
6C4H.Z – Disorders due to use of non-psychoactive substances, unspecified

Sibling codes

6C40 – Disorders due to use of alcohol
6C41 – Disorders due to use of cannabis
6C42 – Disorders due to use of synthetic cannabinoids
6C43 – Disorders due to use of opioids
6C44 – Disorders due to use of sedatives, hypnotics or anxiolytics
6C45 – Disorders due to use of cocaine
6C46 – Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
6C47 – Disorders due to use of synthetic cathinones
6C48 – Disorders due to use of caffeine
6C49 – Disorders due to use of hallucinogens
6C4A – Disorders due to use of nicotine
6C4B – Disorders due to use of volatile inhalants
6C4C – Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]
6C4D – Disorders due to use of dissociative drugs including ketamine or phencyclidine (PCP)
6C4E – Disorders due to use of other specified psychoactive substances, including medications
6C4F – Disorders due to use of multiple specified psychoactive substances, including medications
6C4G – Disorders due to use of unknown or unspecified psychoactive substances
6C4Y – Other specified disorders due to substance use
6C4Z – Disorders due to substance use, unspecified

Foundation entity

Disorders due to use of non-psychoactive substances – http://id.who.int/icd/entity/247116319

Part of: 06: Mental, behavioural or neurodevelopmental disorders